Please login to the form below

Not currently logged in
Email:
Password:

Eric Terhaerdt leaves AZ for Astellas

Joins as senior VP of global development operations

Eric Terhaerdt, AstellasAstellas has turned to AstraZeneca for its new senior VP of global development operations.

Eric Terhaerdt spent more than 20 years at AZ, most recently serving as VP, head of scientific and technical evaluations.

He will now lead the global direction of the drug development operations at Japan-based Astellas, working primarily in the Netherlands and the US.

Terhaerdt has extensive knowledge of the global pharmaceutical market having worked across the world for AZ in countries such as the UK, the US, Sweden, Hungary and the Czech Republic.

Dr Bernie Zeiher, executive VP, global development, welcomed Terhaerdt to the company: "His diverse international experience in drug development, strategic planning and change management will help Astellas continue to address the unmet needs of our patients."

20th January 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics